⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
KURA News
Kura Oncology, Inc.
Kura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
globenewswire.com
KURA
Montara Therapeutics Appoints Andrew Miller to Board of Directors, Names Chief Medical Officer, and Promotes Chief Technology Officer
globenewswire.com
KURA
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
KURA
Form 8-K
sec.gov
KURA
Kura Oncology Highlights Darlifarnib’s Potential as a Foundational Combination Platform for KRAS-Mutant Cancers and Outlines Development Strategy
globenewswire.com
KURA
Kura Oncology and Kyowa Kirin Announce Publication in Blood of Ziftomenib plus Venetoclax / Azacitidine Combination in Patients with R/R NPM1-m AML
globenewswire.com
KURA
Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
KURA
BMY
IPHA
MRK
MNPR
JAZZ
MOLN
LLY
GSK
AGEN
PFE
Kura Oncology Reports Strong Clinical Activity and Safety with Darlifarnib + Adagrasib in KRAS G12C-Mutated Solid Tumors
globenewswire.com
KURA
Kura Oncology to Present at TD Cowen 7th Annual Oncology Innovation Summit
globenewswire.com
KURA
Form 8-K
sec.gov
KURA